阵发性睡眠性血红蛋白尿 (PNH) 治疗全球市场研究报告-行业分析、规模、份额、增长、趋势和预测 2022-2028

Value Market Research 深入研究了全球阵发性睡眠性血红蛋白尿 (PNH) 治疗市场，并预测未来几年该行业将出现显着增长。全球阵发性睡眠性血红蛋白尿 (PNH) 治疗市场报告提供了 2023 年至 2028 年的完整行业分析、市场规模、市场份额、增长趋势和预测。该报告以详细的市场介绍和突出报告关键增长数据的执行摘要开始。以下章节讨论市场价值链、波特五力模型和市场吸引力分析。我们还将有自己的关于 COVID-19 影响分析的章节，以了解市场如何应对这一流行病。

本报告的市场动态部分详细介绍了当前的市场驱动因素和限制因素、挑战和风险以及即将到来的机遇。本节将引起企业战略家和新产品开发部门的极大兴趣。全球阵发性睡眠性血红蛋白尿 (pnh) 治疗市场研究细分市场并提供收入和/或销售方面的市场规模。该数据按地区划分，然后按国家划分。数据是通过深入的初级访谈和来自世界各地的行业专家收集的。详细的研究方法可以在样本报告中找到。这些市场估计还受到最新的社会、政治和经济变化以及当前影响阵发性夜间血红蛋白尿 (pnh) 治疗市场的市场动态的影响。

阵发性睡眠性血红蛋白尿 (pnh) 治疗市场报告的下一部分检查了市场竞争力并介绍了一些主要的市场参与者/製造商。这些部分包含丰富的信息，可帮助您了解竞争对手的产品线、财务状况、最近的市场发展和行业领导者。

报告的目标国家如下。

北美：美国、加拿大、墨西哥

欧洲：英国、德国、法国、意大利、俄罗斯、西班牙、其他欧洲国家

亚太地区：中国、印度、日本、韩国、澳大利亚、亚太地区的其他国家

拉丁美洲：巴西、阿根廷、秘鲁、智利、拉丁美洲其他地区

中东和非洲：沙特阿拉伯、阿联酋、以色列、南非

本报告的市场细分如下：

按产品

药物治疗

干细胞移植

输血

内容

第一章前言

• 本报告的内容
  • 目的
  • 目标受众
  • 独特的销售主张 (USP) 和产品
• 调查范围
• 调查方法
  • 市场调研流程
  • 市场调查方法

第 2 章执行摘要

• 市场亮点
• 全球市场概况

第 3 章阵发性睡眠性血红蛋白尿 (PNH) 治疗 - 行业分析

• 简介 - 市场动态
• 市场驱动力
• 市场製约因素
• 商机
• 行业趋势
• 波特五力分析
• 市场吸引力分析
  • 按处理方法分析市场吸引力
  • 按地区划分的市场吸引力分析

第四章价值链分析

• 价值链分析
• 原材料分析
  • 原材料清单
  • 成分製造商列表
  • 主要原材料价格走势
• 潜在买家名单
• 销售渠道
  • 直接营销
  • 间接营销
  • 新兴市场营销渠道发展趋势

第 5 章 COVID-19 爆发的影响分析

• 分析爆发对 COVID-19 的影响
  • 对生产的直接影响
  • 供应炼和市场中断
  • 对公司和金融市场的财务影响
• 分析 COVID-19 对生产、进口、出口和需求的影响
• 在疫情爆发之前/之后销售 COVID-19
• 预测冠状病毒 (COVID-19) 流行的影响
• COVID-19：微观和宏观因素分析

第 6 章全球阵发性睡眠性血红蛋白尿 (PNH) 治疗市场：按治疗分析

• 按治疗方法总结
• 实际数据和预测数据
• 按处理方法分析
• 按地区划分的药物治疗的实际和预测销售额
• 按地区划分的干细胞移植销售结果和预测
• 各地区输血销售业绩及预测

第 7 章。阵发性睡眠性血红蛋白尿 (PNH) 治疗全球市场分析：按地区划分

• 区域展望
• 简介
• 北美销售分析
  • 概览、过去和未来的销售分析
  • 北美分部销售分析
  • 北美：按国家/地区分列的销售分析
  • 美国销售分析
  • 加拿大销售分析
  • 墨西哥销售分析
• 欧洲销售分析
  • 概览、过去和未来的销售分析
  • 按细分市场划分的欧洲销售分析
  • 欧洲：按国家/地区划分的销售分析
  • 英国销售分析
  • 法国销售分析
  • 德国销售分析
  • 意大利销售分析
  • 俄罗斯销售分析
  • 其他欧洲销售分析
• 亚太地区销售分析
  • 概览、过去和未来的销售分析
  • 亚太地区分部销售分析
  • 按国家/地区划分的亚太地区销售分析
  • 在中国的销售分析
  • 印度销售分析
  • 日本销售分析
  • 韩国销售分析
  • 澳大利亚销售分析
  • 其他亚太地区销售分析
• 拉丁美洲销售分析
  • 概览、过去和未来的销售分析
  • 拉丁美洲分部销售分析
  • 拉丁美洲：按国家/地区分列的销售分析
  • 巴西销售分析
  • 阿根廷销售分析
  • 秘鲁销售分析
  • 智利的销售分析
  • 其他拉丁美洲销售分析
• 中东和非洲销售分析
  • 概览、过去和未来的销售分析
  • 中东和非洲地区分部销售分析
  • 按国家/地区划分的中东和非洲销售分析
  • 沙特阿拉伯销售分析
  • 阿联酋销售分析
  • 以色列销售分析
  • 南非的销售分析
  • 其他中东和非洲销售分析

第 8 章。阵发性夜间血红蛋白尿 (Pnh) 製药公司的竞争状况

• 阵发性睡眠性血红蛋白尿（Pnh）药物市场竞争
• 伙伴关係、协作、协议
• 併购
• 新品发布
• 其他发展

第 9 章公司简介

• 前 10 名公司的市场份额分析
• 市场集中度
• Alexion Pharmaceuticals Inc.
  • 企业概要
  • 企业收益
  • 产品介绍
  • 最近开发情况
• Akari Therapeutics
  • 公司概要
  • 企业收益
  • 产品情报
  • 最近开发情况
• Apellis.
  • 公司概要
  • 企业收益
  • 产品情报
  • 最近开发情况
• Achillion.
  • 公司概要
  • 企业收益
  • 产品情报
  • 最近开发情况
• Others
  • 公司概要
  • 企业收益
  • 产品情报
  • 最近动向

公司简介中的财务和近期发展基于现有信息，可能不适用于私营公司。

Value Market Research deeply researched the Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Market to foresee a significant growth in the industry over the upcoming years. The global paroxysmal nocturnal hemoglobinuria (pnh) treatment market report provides a complete industry analysis, market size, market share, growth trends, and forecasts for 2023 to 2028. The report starts with a detailed market introduction and an executive summary that highlights the report's key growth numbers. The subsequent chapters discuss the value chain of the market, Porter's Five Forces Model, and market attractiveness analysis. An exclusive chapter on COVID-19 impact analysis has been added to understand how the market has responded to the pandemic.

The market dynamics section of the report elaborates the current market drivers, restraints along with the challenges/risks and upcoming opportunities. This section can be of high interest for any company's strategists and new product development department. The global paroxysmal nocturnal hemoglobinuria (pnh) treatment market study segments the market and provides the market size in terms of revenue and/ or sales. This data is bifurcated by region and later by countries. The data is collected through detailed primary interviews and industry experts across the world. The detailed methodology can be seen in our sample reports. These market estimates are also influenced by the latest social, political and economic changes along with the current market dynamics that are affecting this paroxysmal nocturnal hemoglobinuria (pnh) treatment market.

The next sections of the paroxysmal nocturnal hemoglobinuria (pnh) treatment market report studies the market competitiveness and profiles some key market players/manufacturers. These sections are knowledgeable for understanding the competitor's product-line, their financials, recent developments and the top market share owners in the industry.

Countries Covered in the report are as below:

North America - United States, Canada, and Mexico

Europe - United Kingdom, Germany, France, Italy, Russia, Spain & Rest of Europe

Asia-Pacific - China, India, Japan, South Korea, Australia & Rest of APAC

Latin America - Brazil, Argentina, Peru, Chile & Rest of Latin America

Middle East and Africa - Saudi Arabia, UAE, Israel, South Africa

Market Segmentation in the report is as below-

By Product

Medication

Stem Cell Transplant

Blood Transfusion

TABLE OF CONTENTS

1 . PREFACE

• 1.1. Report Description
  • 1.1.1. Objective
  • 1.1.2. Target Audience
  • 1.1.3. Unique Selling Proposition (USP) & offerings
• 1.2. Research Scope
• 1.3. Research Methodology
  • 1.3.1. Market Research Process
  • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

• 2.1. Highlights of Market
• 2.2. Global Market Snapshot

3 . PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) TREATMENT - INDUSTRY ANALYSIS

• 3.1. Introduction - Market Dynamics
• 3.2. Market Drivers
• 3.3. Market Restraints
• 3.4. Opportunities
• 3.5. Industry Trends
• 3.6. Porter's Five Force Analysis
• 3.7. Market Attractiveness Analysis
  • 3.7.1 Market Attractiveness Analysis By Treatment
  • 3.7.2 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

• 4.1. Value Chain Analysis
• 4.2. Raw Material Analysis
  • 4.2.1. List of Raw Materials
  • 4.2.2. Raw Material Manufactures List
  • 4.2.3. Price Trend of Key Raw Materials
• 4.3. List of Potential Buyers
• 4.4. Marketing Channel
  • 4.4.1. Direct Marketing
  • 4.4.2. Indirect Marketing
  • 4.4.3. Marketing Channel Development Trend

5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK

• 5.1. Impact Analysis of Covid-19 Outbreak
  • 5.1.1. Direct Impact on Production
  • 5.1.2. Supply Chain and Market Disruption
  • 5.1.3. Financial Impact on Firms and Financial Markets
• 5.2. COVID-19 Impact Analysis by Production, Import, Export and Demand
• 5.3. Market: Pre V/S Post COVID-19
• 5.4. Estimated Impact of the Coronavirus (COVID-19) Epidemic
• 5.5. COVID-19: Micro and Macro Factor Analysis

6 . GLOBAL PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) TREATMENT MARKET ANALYSIS BY TREATMENT

• 6.1 Overview by Treatment
• 6.2 Historical and Forecast Data
• 6.3 Analysis by Treatment
• 6.4 Medication Historic and Forecast Sales by Regions
• 6.5 Stem Cell Transplant Historic and Forecast Sales by Regions
• 6.6 Blood Transfusion Historic and Forecast Sales by Regions

7 . GLOBAL PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) TREATMENT MARKET ANALYSIS BY GEOGRAPHY

• 7.1. Regional Outlook
• 7.2. Introduction
• 7.3. North America Sales Analysis
  • 7.3.1. Overview, Historic and Forecast Sales Analysis
  • 7.3.2. North America By Segment Sales Analysis
  • 7.3.3. North America By Country Sales Analysis
  • 7.3.4. United State Sales Analysis
  • 7.3.5. Canada Sales Analysis
  • 7.3.6. Mexico Sales Analysis
• 7.4. Europe Sales Analysis
  • 7.4.1. Overview, Historic and Forecast Sales Analysis
  • 7.4.2. Europe by Segment Sales Analysis
  • 7.4.3. Europe by Country Sales Analysis
  • 7.4.4. United Kingdom Sales Analysis
  • 7.4.5. France Sales Analysis
  • 7.4.6. Germany Sales Analysis
  • 7.4.7. Italy Sales Analysis
  • 7.4.8. Russia Sales Analysis
  • 7.4.9. Rest Of Europe Sales Analysis
• 7.5. Asia Pacific Sales Analysis
  • 7.5.1. Overview, Historic and Forecast Sales Analysis
  • 7.5.2. Asia Pacific by Segment Sales Analysis
  • 7.5.3. Asia Pacific by Country Sales Analysis
  • 7.5.4. China Sales Analysis
  • 7.5.5. India Sales Analysis
  • 7.5.6. Japan Sales Analysis
  • 7.5.7. South Korea Sales Analysis
  • 7.5.8. Australia Sales Analysis
  • 7.5.9. Rest Of Asia Pacific Sales Analysis
• 7.6. Latin America Sales Analysis
  • 7.6.1. Overview, Historic and Forecast Sales Analysis
  • 7.6.2. Latin America by Segment Sales Analysis
  • 7.6.3. Latin America by Country Sales Analysis
  • 7.6.4. Brazil Sales Analysis
  • 7.6.5. Argentina Sales Analysis
  • 7.6.6. Peru Sales Analysis
  • 7.6.7. Chile Sales Analysis
  • 7.6.8. Rest of Latin America Sales Analysis
• 7.7. Middle East & Africa Sales Analysis
  • 7.7.1. Overview, Historic and Forecast Sales Analysis
  • 7.7.2. Middle East & Africa by Segment Sales Analysis
  • 7.7.3. Middle East & Africa by Country Sales Analysis
  • 7.7.4. Saudi Arabia Sales Analysis
  • 7.7.5. UAE Sales Analysis
  • 7.7.6. Israel Sales Analysis
  • 7.7.7. South Africa Sales Analysis
  • 7.7.8. Rest Of Middle East And Africa Sales Analysis

8 . COMPETITIVE LANDSCAPE OF THE PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) TREATMENT COMPANIES

• 8.1. Paroxysmal Nocturnal Hemoglobinuria (Pnh) Treatment Market Competition
• 8.2. Partnership/Collaboration/Agreement
• 8.3. Merger And Acquisitions
• 8.4. New Product Launch
• 8.5. Other Developments

9 . COMPANY PROFILES OF PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) TREATMENT INDUSTRY

• 9.1. Top 10 Company Share Analysis
• 9.2. Market Concentration Rate
• 9.3. Alexion Pharmaceuticals Inc.
  • 9.3.1. Company Overview
  • 9.3.2. Company Revenue
  • 9.3.3. Products
  • 9.3.4. Recent Developments
• 9.4. Akari Therapeutics
  • 9.4.1. Company Overview
  • 9.4.2. Company Revenue
  • 9.4.3. Products
  • 9.4.4. Recent Developments
• 9.5. Apellis.
  • 9.5.1. Company Overview
  • 9.5.2. Company Revenue
  • 9.5.3. Products
  • 9.5.4. Recent Developments
• 9.6. Achillion.
  • 9.6.1. Company Overview
  • 9.6.2. Company Revenue
  • 9.6.3. Products
  • 9.6.4. Recent Developments
• 9.7. Others
  • 9.7.1. Company Overview
  • 9.7.2. Company Revenue
  • 9.7.3. Products
  • 9.7.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

• Market Snapshot
• Drivers : Impact Analysis
• Restraints : Impact Analysis
• List of Raw Material
• List of Raw Material Manufactures
• List of Potential Buyers
• COVID-19 Impact Analysis by Production, Import, Export and Demand
• Pre V/S Post COVID-19
• Estimated Impact Of The Coronavirus (Covid-19) Epidemic
• COVID-19: Micro and Macro Factor Analysis
• Analysis by Treatment (USD MN)
• Medication Market Sales by Geography (USD MN)
• Stem Cell Transplant Market Sales by Geography (USD MN)
• Blood Transfusion Market Sales by Geography (USD MN)
• Global Paroxysmal Nocturnal Hemoglobinuria (Pnh) Treatment Market Sales by Geography (USD MN)
• North America Market Analysis (USD MN)
• United State Market Analysis (USD MN)
• Canada Market Analysis (USD MN)
• Mexico Market Analysis (USD MN)
• Europe Market Analysis (USD MN)
• Europe Market Estimate by Country (USD MN)
• United Kingdom Market Analysis (USD MN)
• France Market Analysis (USD MN)
• Germany Market Analysis (USD MN)
• Italy Market Analysis (USD MN)
• Russia Market Analysis (USD MN)
• Spain Market Analysis (USD MN)
• Rest of Europe Market Analysis (USD MN)
• Asia Pacific Market Analysis (USD MN)
• China Market Analysis (USD MN)
• Japan Market Analysis (USD MN)
• India Market Analysis (USD MN)
• South Korea Market Analysis (USD MN)
• Australia Market Analysis (USD MN)
• Rest of Asia Pacific Market Analysis (USD MN)
• Latin America Market Analysis (USD MN)
• Brazil Market Analysis (USD MN)
• Argentina Market Analysis (USD MN)
• Peru Market Analysis (USD MN)
• Chile Market Analysis (USD MN)
• Rest of Latin America Market Analysis (USD MN)
• Middle East & Africa Market Analysis (USD MN)
• Saudi Arabia Market Analysis (USD MN)
• UAE Market Analysis (USD MN)
• Israel Market Analysis (USD MN)
• South Africa Market Analysis (USD MN)
• Rest of Middle East and Africa Market Analysis (USD MN)
• Partnership/Collaboration/Agreement
• Mergers And Acquisiton

LIST OF FIGURES

• Research Scope of Paroxysmal Nocturnal Hemoglobinuria (Pnh) Treatment Report
• Market Research Process
• Market Research Methodology
• Global Paroxysmal Nocturnal Hemoglobinuria (Pnh) Treatment Market Size, by Region (USD MN)
• Porters Five Forces Analysis
• Market Attractiveness Analysis by Treatment
• Market Attractiveness Analysis by Region
• Value Chain Analysis
• Global Market Analysis by Treatment (USD MN)
• Medication Market Sales by Geography (USD MN)
• Stem Cell Transplant Market Sales by Geography (USD MN)
• Blood Transfusion Market Sales by Geography (USD MN)
• Global Market by Revenue
• North America Market by Revenue
• Europe Market by Revenue
• Asia Pacific Market by Revenue
• Latin America Market by Revenue
• Middle East & Africa Market by Revenue
• Recent Development in Industry
• Top Companies Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.